Abstract
The effects of androgens on lipid transport and metabolism have been reviewed. These effects are probably independent of the androgenic and anabolic activities of the androgens, although the molecular mechanism of action is still not known. Presumably the lowering by androgens of the concentrations of serum lipids and lipoproteins could be the consequence possibly of a primary, inhibitory effect on the synthesis of apolipoprotein A. In addition the role of increased lipolytic activities in plasma and of effects on intermediatry metabolism has been considered.
Similar content being viewed by others
References
Wilson, J.D., N. Bruchovsky and J.N. Chatfield, in “Progress in Endocrinology,” Excerpta Medica Found,” Amsterdam, 1969, p. 17.
Eberlein, W.R., J. Winter and R.L. Rosenfield, in “Hormones in Blood”, Vol. 2., Edited by C.H. Gray and A.L. Bacharach, Academic Press, New York, 1967, p. 187.
Mausvais-Jarvis, P., H.H. Floch and J. Bercovici, J. Clin. Endocr. 28:460 (1968).
Applezweig, N., “Steroid Drugs,” McGraw-Hill Co., New York, 1962, p. 93.
Kochakian, C.D., and C.E. Stettner, Am. J. Physiol. 155:255 (1948).
Korner, A., and F.G. Young, J. Endocrinol. 13:78 (1955).
Laron, A., and A. Kowadlo-Silbergeld, Acta Endocrinol. 45:427 (1964).
Laron, Z., and A. Kowadlo-Silbergeld, Israel J. Med. Sci. 1:91 (1965).
Glueck, C.J., D. Scheel, J. Fishback and P. Steiner JAOCS 49:110 (1972).
Furman, R.H., P. Alaupovic, R.H. Bradford and R.P. Howard, Progr. Biochem. Pharmacol. 4:334 (1968).
Hatch, F.T., and R.S. Lees, Advan. Lipid Res. 6:1 (1968).
Furman, R.H., P. Alaupovic and R.P. Howard, Progr. Biochem. Pharmacol. 2:215 (1967).
Russ, E.M., H.A. Eder and D.P. Barr, Am. J. Med. 19:4 (1955).
Berezin, D., and W. von Studnitz, Acta Endocrinol. 25:435 (1957).
Furman, R.H., L.N. Norcia, C.W. Robinson, Jr., and I.E. Gonzales, Am. J. Physiol. 191:561 (1957).
Pick, R., J. Stamler, S. Rodbard and L.N. Katz, Circulation Res. 7:202 (1959).
Fillios, L.C., Endrocrinology 60:22 (1957).
Oliver, M.F., and G.S. Boyd, Lancet 2:1273 (1956).
Furman, R.H., and R.P. Howard, Ann. Internal Med. 47:969 (1957).
Abell, L.L., E.H. Mosbach and F.E. Kendall, Circulation Res. 10:846 (1962).
Furman, R.H., C.W. Robinson, Jr., R.H. Bradford, P. Alaupovic and L.N. Norcia, Proc. Soc. Exp. Biol. (N.Y.) 113:789 (1963).
Solyom, A., R.H. Bradford and R.H. Furman Biochim. Biophys. Acta 236:563 (1971).
Abell, L.L., and E.H. Mosbach, J. Lipid Res. 3:88 (1962).
Hellman, L., H.L. Bradlow, B. Zumoff, D.K. Fukushima and T.F. Gallagher, J. Clin. Endocr. Metab. 19:936 (1959).
Furman, R.H., and R.P. Howard, Metabolism 11:76 (1962).
Furman, R.H., R.P. Howard, L.N. Norcia and E.C. Keaty, Am. J. Med. 24:80 (1958).
Howard, R.P., and Furman, R.H., Ann. Internal Med. 56:688 (1962).
Abell, L.L., and E.H. Mosbach, J. Lipid Res. 9:98 (1968).
Gofman, J.W., L. Robin, J.P. McGinley and H.B. Jones, Am. J. Med. 17:514 (1954).
Jones, R.J., L. Cohen and H. Corbus, Ibid. 19:71 (1955).
Furman, R.H., R.P. Howard, K. Lakshmi and L.N. Norcia, Am. J. Clin. Nutr. 9:73 (1961).
Cornwell, D.G., F.A. Kruger, G.J. Hamwi and J.B. Brown, Ibid. 9:24 (1961).
Miller, H., J.A. Durant, J.M. Cowan, J.M.S. Knott and E.S. Garnett, J. Endocr. 48:55 (1970).
Wilson, H., and S. Schenker, Acta Endocrinol. 46:197 (1964).
Adlercreutz, H., J. Kerstell, A. Svanborg and R. Vihko, Ann. Med. Esp. Fenn. 46:165 (1968).
Rao, L.G.S., Lancet 2:390 (1970).
Southren, A.L., and G.G. Gordon, Mount Sinai J. Med. (N.Y.) 37:516 (1970).
Sonka, J., I. Gragorova, J. Pav and F. Skrha, Lancet 2:44 (1964).
Marks, P.A., and J. Banks, Proc. Natl. Acad. Sci. 46:447 (1960).
Felt, V., and L. Starka, Cor et vasa 8: 40 (1966).
Ben-David, M., S. Dikstein, G. Bismuth and F.G. Sulman, Proc. Soc. Exp. Biol. (N.Y.) 125:1136 (1967).
Nakamura, K., Y. Masuda and H. Nakamura, J. Atherosclerosis Res. 7:253 (1967).
Nakamura, K., H. Nakamura, Y. Masuda and Y. O’Saki, Naunyn-Schmiedebergs: Arch. Pharmack. 264:327 (1969).
Solyom, A., R.H. Bradford and R.H. Furman, Biochim. Biophys. Acta 229:471 (1971).
Solyom, A., R.H. Bradford and R.H. Furman, Am. J. Physiol. 221:1587 (1971).
Oberdorfer, A., Acta Endocrinol. 64(Suppl.):143 (1970).
Ingbar, S.H., in “Progress in Endocrinology”, Excerpta Medica Found., Amsterdam, 1969, p. 1200.
Federman, D.D., J. Robbins and J.E. Rall, J. Clin. Invest. 37:1024 (1958).
Havel, R.J., V.G. Shore, B. Shore and D.M. Bier, Circulation Res. 27:595 (1970).
LaRosa, J.C., R.I. Levy, P. Herbert, S.E. Lux and D.S. Fredrickson, Biochem. Biophys. Res. Commun. 41:57 (1970).
Ganesan, D., R.H. Bradrod, P. Alaupovic and W.J. McConathy, Fed. Proc. 30:208 (1971).
Ritter, M.C., and M.E. Dempsey, J. Biol. Chem. 246:1536 (1971).
Scallen, T.J., M.W. Schuster, A.K. Dhar and H.B. Skrdlant, Lipids 6:162 (1970).
Trams, E.G., and E.A. Brown, J. Theoret. Biol. 12:311 (1966).
Farber, E., and A. Segaloff, J. Biol. Chem. 216:471 (1955).
Windmueller, H.G., and R.I. Levy, Ibid. 242:2246 (1967).
Author information
Authors and Affiliations
Additional information
Special Fellowship Awardee (1F11 NSO2245-01) from the National Institute of Neurological Diseases and Stroke
About this article
Cite this article
Solyom, A. Effect of androgens on serum lipids and lipoproteins. Lipids 7, 100–105 (1972). https://doi.org/10.1007/BF02532595
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02532595